XML 26 R16.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements
6 Months Ended
Mar. 31, 2021
Fair Value Disclosures [Abstract]  
Fair Value Measurements

8. Fair Value Measurements

Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants in the principal or most advantageous market for the asset or liability. There are three levels of inputs that are used to measure fair value:

 

Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities;

 

Level 2: inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or

 

Level 3: unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

Time deposits and corporate notes/bonds are classified within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets.

Foreign currency derivative contracts are typically classified within Level 2 of the fair value hierarchy. The principal market in which we execute our foreign currency derivatives is the institutional market in an over-the-counter environment with a relatively high level of price transparency. The market participants are usually large financial institutions. Our foreign currency derivatives’ valuation inputs are based on quoted prices and quoted pricing intervals from public data sources and do not involve management judgment.

Our significant financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2021 and September 30, 2020 were as follows:

 

(in thousands)

 

March 31, 2021

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Financial assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

$

115,533

 

 

$

 

 

$

 

 

$

115,533

 

Derivative instruments

 

 

 

 

 

6,846

 

 

 

 

 

 

6,846

 

Convertible note

 

 

 

 

 

 

 

 

1,000

 

 

 

1,000

 

Total financial assets

 

$

115,533

 

 

$

6,846

 

 

$

1,000

 

 

$

123,379

 

Financial liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Forward contracts

 

 

 

 

 

4,259

 

 

 

 

 

 

4,259

 

Total financial liabilities

 

$

 

 

$

4,259

 

 

$

 

 

$

4,259

 

 

(in thousands)

 

September 30, 2020

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Financial assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

$

105,299

 

 

$

 

 

$

 

 

$

105,299

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate notes/bonds

 

 

59,099

 

 

 

 

 

 

 

 

 

59,099

 

Derivative instruments

 

 

 

 

 

903

 

 

 

 

 

 

903

 

Total financial assets

 

$

164,398

 

 

$

903

 

 

$

 

 

$

165,301

 

Financial liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Forward contracts

 

 

 

 

 

1,073

 

 

 

 

 

 

1,073

 

Total financial liabilities

 

$

 

 

$

1,073

 

 

$

 

 

$

1,073

 

 

Level 3 Debt Investments

 

In the first quarter of 2021, we invested $1.0 million into a non-marketable convertible note. This debt security is classified as available-for-sale and is included in other assets on the Consolidated Balance Sheet. There were not any changes in the fair value of this level 3 investment in the three and six months ended March 31, 2021.

 

Non-Marketable Equity Investments

The carrying value of our non-marketable equity investments is recorded in other assets on the Consolidated Balance Sheets and totaled $8.9 million as of both March 31, 2021 and September 30, 2020.